OCT 20, 2026 · JOURNAL ARTICLE
When drug repurposing backfires: antagonistic effects of ivermectin on cisplatin therapy in oral cancer
BMC Pharmacology and Toxicology
Cisplatin (CIS) remains the gold standard chemotherapeutic agent for the management of oral cancer. However, its clinical efficacy is frequently limited by chemoresistance and dose